EUROPA trial

Interim results from the EUROPA trial presented at SABCS24 – The Lancet Oncology

The Lancet Oncology shared a recent article on X:

“Presented at SABCS24: Interim results from the EUROPA trial: Single-modality endocrine therapy vs radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal a-like early breast cancer.”

Title: Single-modality endocrine therapy versus radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal A-like early breast cancer (EUROPA): a preplanned interim analysis of a phase 3, non-inferiority, randomised trial

Authors: Icro Meattini, Maria Carmen De Santis, Luca Visani, Marta Scorsetti, Alessandra Fozza, Bruno Meduri, Fiorenza De Rose, Elisabetta Bonzano, Agnese Prisco, Valeria Masiello, Eliana La Rocca, Ruggero Spoto, Carlotta Becherini, Gladys Blandino, Luca Moscetti, Riccardo Ray Colciago, Riccardo A Audisio, Etienne Brain, Saverio Caini, Marije Hamaker, Orit Kaidar-Person, Matteo Lambertini, Livia Marrazzo, Calogero Saieva, Tanja Spanic, Vratislav Strnad, Sally Wheelwright, Philip M P Poortmans and Lorenzo Livi

The Lancet Oncology

More posts featuring The Lancet Oncology.

Breast Cancer breast conserving surgery cancer endocrine endocrine therapy EUROPA trial Icro Meattini Lorenzo Livi Luca Visani Maria Carmen De Santis Marta Scorsetti OncoDaily Oncology Philip M P Poortmans radiotherapy SABCS24 Sally Wheelwright The Lancet Oncology